124 related articles for article (PubMed ID: 20357812)
1. Functional modulation of IGF-binding protein-3 expression in melanoma.
Dar AA; Majid S; Nosrati M; de Semir D; Federman S; Kashani-Sabet M
J Invest Dermatol; 2010 Aug; 130(8):2071-9. PubMed ID: 20357812
[TBL] [Abstract][Full Text] [Related]
2. DSS1 promoter hypomethylation and overexpression predict poor prognosis in melanoma and squamous cell carcinoma patients.
Venza M; Visalli M; Catalano T; Beninati C; Teti D; Venza I
Hum Pathol; 2017 Feb; 60():137-146. PubMed ID: 27825810
[TBL] [Abstract][Full Text] [Related]
3. Silencing of the thrombomodulin gene in human malignant melanoma.
Furuta J; Kaneda A; Umebayashi Y; Otsuka F; Sugimura T; Ushijima T
Melanoma Res; 2005 Feb; 15(1):15-20. PubMed ID: 15714116
[TBL] [Abstract][Full Text] [Related]
4. Identification of upstream stimulatory factor binding sites in the human IGFBP3 promoter and potential implication of adjacent single-nucleotide polymorphisms and responsiveness to insulin.
Paquette J; Bessette B; Ledru E; Deal C
Endocrinology; 2007 Dec; 148(12):6007-18. PubMed ID: 17823260
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells.
Mori T; Kim J; Yamano T; Takeuchi H; Huang S; Umetani N; Koyanagi K; Hoon DS
Cancer Res; 2005 Mar; 65(5):1800-7. PubMed ID: 15753377
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic and functional analysis of IGFBP3 and IGFBPrP1 in cellular immortalization.
Fridman AL; Rosati R; Li Q; Tainsky MA
Biochem Biophys Res Commun; 2007 Jun; 357(3):785-91. PubMed ID: 17451653
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma.
Rubinstein JC; Tran N; Ma S; Halaban R; Krauthammer M
BMC Med Genomics; 2010 Feb; 3():4. PubMed ID: 20144234
[TBL] [Abstract][Full Text] [Related]
8. ASC/TMS1, a caspase-1 activating adaptor, is downregulated by aberrant methylation in human melanoma.
Guan X; Sagara J; Yokoyama T; Koganehira Y; Oguchi M; Saida T; Taniguchi S
Int J Cancer; 2003 Nov; 107(2):202-8. PubMed ID: 12949795
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis by IGFBP3 overexpression in hepatocellular carcinoma cells.
Han JJ; Xue DW; Han QR; Liang XH; Xie L; Li S; Wu HY; Song B
Asian Pac J Cancer Prev; 2014; 15(23):10085-9. PubMed ID: 25556430
[TBL] [Abstract][Full Text] [Related]
10. Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma.
Kong WJ; Zhang S; Guo CK; Wang YJ; Chen X; Zhang SL; Zhang D; Liu Z; Kong W
Anticancer Drugs; 2006 Mar; 17(3):251-9. PubMed ID: 16520653
[TBL] [Abstract][Full Text] [Related]
11. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
Meng CF; Zhu XJ; Peng G; Dai DQ
Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
[TBL] [Abstract][Full Text] [Related]
12. Promoter methylation inhibits APC gene expression by causing changes in chromatin conformation and interfering with the binding of transcription factor CCAAT-binding factor.
Deng G; Song GA; Pong E; Sleisenger M; Kim YS
Cancer Res; 2004 Apr; 64(8):2692-8. PubMed ID: 15087381
[TBL] [Abstract][Full Text] [Related]
13. Thrombospondin-1 expression in melanoma is blocked by methylation and targeted reversal by 5-Aza-deoxycytidine suppresses angiogenesis.
Lindner DJ; Wu Y; Haney R; Jacobs BS; Fruehauf JP; Tuthill R; Borden EC
Matrix Biol; 2013 Mar; 32(2):123-32. PubMed ID: 23202046
[TBL] [Abstract][Full Text] [Related]
14. Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylation.
Hanafusa T; Shinji T; Shiraha H; Nouso K; Iwasaki Y; Yumoto E; Ono T; Koide N
BMC Cancer; 2005 Jan; 5():9. PubMed ID: 15661074
[TBL] [Abstract][Full Text] [Related]
15. Silencing and re-expression of retinoic acid receptor beta2 in human melanoma.
Fan J; Eastham L; Varney ME; Hall A; Adkins NL; Chetel L; Sollars VE; Georgel P; Niles RM
Pigment Cell Melanoma Res; 2010 Jun; 23(3):419-29. PubMed ID: 20374520
[TBL] [Abstract][Full Text] [Related]
16. 5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation.
Scott SA; Dong WF; Ichinohasama R; Hirsch C; Sheridan D; Sanche SE; Geyer CR; Decoteau JF
Leuk Res; 2006 Jan; 30(1):69-76. PubMed ID: 16043219
[TBL] [Abstract][Full Text] [Related]
17. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
Magdinier F; Wolffe AP
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.
Kim TY; Jong HS; Song SH; Dimtchev A; Jeong SJ; Lee JW; Kim TY; Kim NK; Jung M; Bang YJ
Oncogene; 2003 Jun; 22(25):3943-51. PubMed ID: 12813468
[TBL] [Abstract][Full Text] [Related]
19. Use of integrative epigenetic and cytogenetic analyses to identify novel tumor-suppressor genes in malignant melanoma.
Mithani SK; Smith IM; Califano JA
Melanoma Res; 2011 Aug; 21(4):298-307. PubMed ID: 21606880
[TBL] [Abstract][Full Text] [Related]
20. Amyloid beta-mediated epigenetic alteration of insulin-like growth factor binding protein 3 controls cell survival in Alzheimer's disease.
Sung HY; Choi EN; Lyu D; Mook-Jung I; Ahn JH
PLoS One; 2014; 9(6):e99047. PubMed ID: 24964199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
